Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice

Prevalence of Drug Resistance Mutations in Protease, Reverse Transcriptase, and Integrase Genes of North Central Mexico HIV Isolates

(2018) Pedro Gerardo Hernandez-Sanchez et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Prevalence of Integrase Strand Transfer Inhibitors Resistance Mutations in Integrase Strand Transfer Inhibitors-Naive and -Experienced HIV-1 Infected Patients: A Single Center Experience

(2018) Maria Antonia De Francesco et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA Panel

(2018) Huldrych F Günthard et al.   CLINICAL INFECTIOUS DISEASES

Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen

(2018) Charlotte Charpentier et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Evolution of HIV-1 transmitted drug resistance in Italy in the 2007–2014 period: A weighted analysis

(2018) M. Franzetti et al.   JOURNAL OF CLINICAL VIROLOGY

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

(2018) Pedro Cahn et al.   LANCET

Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013–2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors

(2017) Samantha Andreis et al.   Journal of Global Antimicrobial Resistance

Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection

(2016) J. Ambrosioni et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study

(2016) Alexandra U. Scherrer et al.   JOURNAL OF INFECTIOUS DISEASES

Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

(2016) John Gregson et al.   LANCET INFECTIOUS DISEASES

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

(2015) L. Marije Hofstra et al.   CLINICAL INFECTIOUS DISEASES

Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007–2012)

(2015) S. Monge et al.   CLINICAL MICROBIOLOGY AND INFECTION

HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007–12: impact on susceptibility to first-line strategies

(2015) Pierre Frange et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades

(2015) Tomas Doyle et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Infection with the frequently transmitted HIV-1 M41L variant has no influence on selection of tenofovir resistance

(2014) Marieke Pingen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinically Relevant Transmitted Drug Resistance to First Line Antiretroviral Drugs and Implications for Recommendations

(2014) Susana Monge et al.   PLoS One

Analysis of transmitted drug resistance in Spain in the years 2007–2010 documents a decline in mutations to the non-nucleoside drug class

(2012) S. Monge et al.   CLINICAL MICROBIOLOGY AND INFECTION

Transmission of HIV drug resistance and non-B subtype distribution in the Spanish cohort of antiretroviral treatment naïve HIV-infected individuals (CoRIS)

(2011) Federico García et al.   ANTIVIRAL RESEARCH

Transmission of integrase strand-transfer inhibitor multidrug-resistant HIV-1: case report and response to raltegravir-containing antiretroviral therapy

(2011) Benjamin Young et al.   ANTIVIRAL THERAPY

Transmitted raltegravir resistance in an HIV-1 CRF_AG-infected patient

(2011) Sarita D Boyd et al.   ANTIVIRAL THERAPY

La cohorte de la red española de investigación en sida y su biobanco: organización, principales resultados y pérdidas al seguimiento

(2011) Paz Sobrino-Vegas et al.   ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

(2011) Linda Wittkop et al.   LANCET INFECTIOUS DISEASES

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study

(2011) Raph L Hamers et al.   LANCET INFECTIOUS DISEASES

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

(2009) Diane E. Bennett et al.   PLoS One

The Spanish HIV BioBank: a model of cooperative HIV research

(2009) Isabel Garcia-Merino et al.   Retrovirology